Unknown

Dataset Information

0

Imported SARS-COV-2 Variants of Concern Drove Spread of Infections Across Kenya During the Second Year of the Pandemic.


ABSTRACT:

Background

Using classical and genomic epidemiology, we tracked the COVID-19 pandemic in Kenya over 23 months to determine the impact of SARS-CoV-2 variants on its progression.

Methods

SARS-CoV-2 surveillance and testing data were obtained from the Kenya Ministry of Health, collected daily from 306 health facilities. COVID-19-associated fatality data were also obtained from these health facilities and communities. Whole SARS-CoV-2 genome sequencing were carried out on 1241 specimens.

Results

Over the pandemic duration (March 2020 - January 2022) Kenya experienced five waves characterized by attack rates (AR) of between 65.4 and 137.6 per 100,000 persons, and intra-wave case fatality ratios (CFR) averaging 3.5%, two-fold higher than the national average COVID-19 associated CFR. The first two waves that occurred before emergence of global variants of concerns (VoC) had lower AR (65.4 and 118.2 per 100,000). Waves 3, 4, and 5 that occurred during the second year were each dominated by multiple introductions each, of Alpha (74.9% genomes), Delta (98.7%), and Omicron (87.8%) VoCs, respectively. During this phase, government-imposed restrictions failed to alleviate pandemic progression, resulting in higher attack rates spread across the country.

Conclusions

The emergence of Alpha, Delta, and Omicron variants was a turning point that resulted in widespread and higher SARS-CoV-2 infections across the country.

SUBMITTER: Nasimiyu C 

PROVIDER: S-EPMC8902869 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>Using classical and genomic epidemiology, we tracked the COVID-19 pandemic in Kenya over 23 months to determine the impact of SARS-CoV-2 variants on its progression.<h4>Methods</h4>SARS-CoV-2 surveillance and testing data were obtained from the Kenya Ministry of Health, collected daily from 306 health facilities. COVID-19-associated fatality data were also obtained from these health facilities and communities. Whole SARS-CoV-2 genome sequencing were carried out on 1241 specime  ...[more]

Similar Datasets

| S-EPMC9382597 | biostudies-literature
| S-EPMC9387217 | biostudies-literature
| S-EPMC5819418 | biostudies-literature
| S-EPMC8662202 | biostudies-literature
| S-EPMC8212592 | biostudies-literature
| S-EPMC11003692 | biostudies-literature
| S-EPMC9470152 | biostudies-literature
| S-EPMC8661965 | biostudies-literature
| S-EPMC10106114 | biostudies-literature
| S-EPMC8270730 | biostudies-literature